BBNX ALERT: Securities Fraud Class Action Launched Against Beta Bionics, Inc. - November 3, 2026 Deadline

Levi & Korsinsky announced a securities fraud class action filed against Beta Bionics on behalf of investors who purchased BBNX securities between July 30, 2025 and February 24, 2026. The complaint alleges executives downplayed an FDA Form 483 that identified over 18,000 device complaints among fewer than 30,000 iLet users, including life-threatening hypoglycemic events the company allegedly failed to investigate or report.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.